ACIP, CDC, and Insurance Coverage of Vaccines in the United States
This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to ACIP and the CDC.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to ACIP and the CDC.
Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.
In his latest column, KFF’s President and CEO Drew Altman discusses how the low levels of trust in the CDC and FDA today seen in KFF’s recent survey findings present a danger should the country face another epidemic.
Five years after the start of COVID-19 pandemic and the communications challenges, divisions, and false claims that followed, less than half of the public say they have at least some confidence in the federal government’s health agencies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) to carry…
As the Trump administration overhauls government health agencies, partisan trust in these agencies on vaccines has shifted and few express confidence in their ability to carry out key tasks. Most adults are confident in the safety of routine vaccines, but the COVID-19 vaccines remain polarizing with many uncertain about false claims regarding mRNA technology.
As Marketplace Open Enrollment nears, policy changes could leave millions of people facing substantially higher premiums and coverage loss, which could lead more consumers to purchase less expensive and less comprehensive coverage through short-term health plans. KFF analyzes short-term health policies sold by nine large insurers in 36 states, examining premiums, cost sharing, covered benefits, and coverage limitations and comparing them to ACA Marketplace plans.
Following the Trump administration’s warning last month that using acetaminophen – the active ingredient in Tylenol – during pregnancy can increase the risk of autism in children, very few adults say the claim about a causal relationship is “definitely true,” though much of the public is uncertain whether to believe it. Trust in the CDC to provide reliable vaccine information has fallen to a new low.
States have begun to form "health alliances" as a counter to federal public health recommendations and policies under the Trump Administration. This Policy Watch describes the goals of these alliances, and discusses what effects they may have for U.S. public health policy.
As federal vaccine policy changes, this poll finds that most adults do not expect to get a COVID-19 vaccine this fall , and many parents are confused and uncertain about whether the vaccine is recommended for healthy children this year. About one in five adults nationally say the changes to vaccine policy are making people safer, while more than a third say they are making people less safe.
This policy watch post examines the United States’ measles elimination status, including what it means to eliminate measles, whether the current measles outbreak could threaten the country’s measles elimination status, and what losing that status might mean for measles control.
© 2025 KFF